Kyverna Therapeutics (KYTX) Prepaid Assets (2023 - 2026)
Kyverna Therapeutics posted quarterly Prepaid Assets of $5.3 million for Q1 2026, up 5.56% year-on-year from $5.0 million in Q1 2025, and up 42.7% on a QoQ basis from $3.7 million in Q4 2025.
Kyverna Therapeutics (KYTX) has 4 years of Prepaid Assets data on file, last reported at $5.3 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 5.56% year-over-year to $5.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.3 million (up 5.56% YoY), and the FY2025 full-year result was $3.7 million, down 19.95% from the prior year.
- Prepaid Assets for Q1 2026 stood at $5.3 million, up from $3.7 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $5.7 million in Q1 2024 and bottomed at $2.6 million in Q2 2024.
- The 4-year median for Prepaid Assets is $3.8 million (2024), against an average of $4.0 million.
- The widest annual swing landed in 2024, when Prepaid Assets soared 48.09%; it then dropped 19.95% in 2025.
- A 4-year view of Prepaid Assets shows it stood at $3.1 million in 2023, then jumped by 48.09% to $4.6 million in 2024, then decreased by 19.95% to $3.7 million in 2025, then surged by 42.7% to $5.3 million in 2026.
- The last three Prepaid Assets figures came in at $5.3 million (Q1 2026), $3.7 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Kyverna Therapeutics | 497.98 Mn | 265.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.28 Mn |
| Dec 31, 2025 | 3.70 Mn |
| Sep 30, 2025 | 3.79 Mn |
| Jun 30, 2025 | 2.65 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Sep 30, 2024 | 3.79 Mn |
| Jun 30, 2024 | 2.59 Mn |
| Mar 31, 2024 | 5.69 Mn |
| Dec 31, 2023 | 3.12 Mn |